Efficacia e tollerabilità dell'Oxcarbazepina nel trattamento dell'epilessia tumorale

A. Zarabla; M. Maschio; L. Dinapoli; A. Fabi; A. Mirri; A. Pace; C. M. Carapella; A. Pompili; E. Occhipinti; B. Jandolo

Efficacia e tollerabilità dell'Oxcarbazepina nel trattamento dell'epilessia tumorale

Translated title of the contribution: Efficacy and tolerability of Oxcarbazepine in brain tumours and epilepsy

A. Zarabla, M. Maschio, L. Dinapoli, A. Fabi, A. Mirri, A. Pace, C. M. Carapella, A. Pompili, E. Occhipinti, B. Jandolo

Istituto Regina Elena

Research output: Contribution to journal › Article › peer-review

Abstract

The aim of this retrospective study was to investigate the safety and efficacy of Oxcarbazepine (OXC) in monotherapy in patients with brain tumour and epilepsy. We studied 21 patients; in 8 patients OXC was the first therapeutic choice, in 13 it substituted the first therapy. Oxcarbazepine induced no side effects. OXC induced a complete seizures control in 14 patients, a seizures rate reduction higher than 50% in 4 patients, an unmodified seizures rate in 2 patients. These preliminary data seem to indicate that OXC treatment in patients with brain tumours is quite safe and effective.

Translated title of the contribution	Efficacy and tolerability of Oxcarbazepine in brain tumours and epilepsy
Original language	Italian
Pages (from-to)	261-262
Number of pages	2
Journal	Bollettino - Lega Italiana contro l'Epilessia
Issue number	133-134
Publication status	Published - Jul 2006

ASJC Scopus subject areas

Clinical Neurology

Cite this

Efficacia e tollerabilità dell'Oxcarbazepina nel trattamento dell'epilessia tumorale. / Zarabla, A.; Maschio, M.; Dinapoli, L.; Fabi, A.; Mirri, A.; Pace, A.; Carapella, C. M.; Pompili, A.; Occhipinti, E.; Jandolo, B.

In: Bollettino - Lega Italiana contro l'Epilessia, No. 133-134, 07.2006, p. 261-262.

Research output: Contribution to journal › Article › peer-review

@article{073d06c2eff845d8ae14066075557f4d,

title = "Efficacia e tollerabilit{\`a} dell'Oxcarbazepina nel trattamento dell'epilessia tumorale",

abstract = "The aim of this retrospective study was to investigate the safety and efficacy of Oxcarbazepine (OXC) in monotherapy in patients with brain tumour and epilepsy. We studied 21 patients; in 8 patients OXC was the first therapeutic choice, in 13 it substituted the first therapy. Oxcarbazepine induced no side effects. OXC induced a complete seizures control in 14 patients, a seizures rate reduction higher than 50% in 4 patients, an unmodified seizures rate in 2 patients. These preliminary data seem to indicate that OXC treatment in patients with brain tumours is quite safe and effective.",

keywords = "Brain tumours, Epilepsy, Oxcarbazepine",

author = "A. Zarabla and M. Maschio and L. Dinapoli and A. Fabi and A. Mirri and A. Pace and Carapella, {C. M.} and A. Pompili and E. Occhipinti and B. Jandolo",

year = "2006",

month = jul,

language = "Italian",

pages = "261--262",

journal = "Bollettino - Lega Italiana contro l'Epilessia",

issn = "0394-560X",

publisher = "Lega Italiana contro l'Epilessia",

number = "133-134",

}

TY - JOUR

T1 - Efficacia e tollerabilità dell'Oxcarbazepina nel trattamento dell'epilessia tumorale

AU - Zarabla, A.

AU - Maschio, M.

AU - Dinapoli, L.

AU - Fabi, A.

AU - Mirri, A.

AU - Pace, A.

AU - Carapella, C. M.

AU - Pompili, A.

AU - Occhipinti, E.

AU - Jandolo, B.

PY - 2006/7

Y1 - 2006/7

N2 - The aim of this retrospective study was to investigate the safety and efficacy of Oxcarbazepine (OXC) in monotherapy in patients with brain tumour and epilepsy. We studied 21 patients; in 8 patients OXC was the first therapeutic choice, in 13 it substituted the first therapy. Oxcarbazepine induced no side effects. OXC induced a complete seizures control in 14 patients, a seizures rate reduction higher than 50% in 4 patients, an unmodified seizures rate in 2 patients. These preliminary data seem to indicate that OXC treatment in patients with brain tumours is quite safe and effective.

AB - The aim of this retrospective study was to investigate the safety and efficacy of Oxcarbazepine (OXC) in monotherapy in patients with brain tumour and epilepsy. We studied 21 patients; in 8 patients OXC was the first therapeutic choice, in 13 it substituted the first therapy. Oxcarbazepine induced no side effects. OXC induced a complete seizures control in 14 patients, a seizures rate reduction higher than 50% in 4 patients, an unmodified seizures rate in 2 patients. These preliminary data seem to indicate that OXC treatment in patients with brain tumours is quite safe and effective.

KW - Brain tumours

KW - Epilepsy

KW - Oxcarbazepine

UR - http://www.scopus.com/inward/record.url?scp=33847642893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847642893&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:33847642893

SP - 261

EP - 262

JO - Bollettino - Lega Italiana contro l'Epilessia

JF - Bollettino - Lega Italiana contro l'Epilessia

SN - 0394-560X

IS - 133-134

ER -

Efficacia e tollerabilità dell'Oxcarbazepina nel trattamento dell'epilessia tumorale

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this